---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-24-000251"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2024-02-20T23:59:59+00:00"
generated_at: "2026-06-05T22:42:01.367720+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics regains Nasdaq minimum bid price compliance; panel monitor for one year

## Summary
- Nasdaq notified Alaunos on Feb 16, 2024 that it has regained compliance with the $1.00 bid price requirement.
- All applicable criteria for continued listing are satisfied; the listing matter is closed.
- Subject to mandatory panel monitor under Nasdaq Rule 5815(d)(4)(B) through Feb 16, 2025.

## SEC filing metadata
- accession: 0001193805-24-000251
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2024-02-20T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000119380524000251/0001193805-24-000251-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000119380524000251/e619290_8k-at.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-24-000251
- JSON: https://secwatch.observer/filing/0001193805-24-000251.json
- Plain text: https://secwatch.observer/filing/0001193805-24-000251.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.